Xiamen Humanity Hospital
| China | Turkey | Austria | |
| Nephrectomy with Da Vinci Robot | from $24,500 | from $16,650 | from $16,000 |
Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.
Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.
Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.
Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.
He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.
Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.
He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).
Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).
He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.
Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.
Chinese tertiary hospitals treat both functional and non-functional adrenal tumors. Specialized centers use standardized clinical protocols for hormonal evaluation and malignancy risk. Functional tumors typically require surgical intervention. Non-functional masses are often monitored via active surveillance. Major medical centers employ robotic-assisted laparoscopic surgery and advanced cryoablation.
Bookimed Expert Insight: Patient volume often signals surgical proficiency in China. Xiamen Humanity Hospital serves 1,000,000 patients annually across 47 departments. This massive caseload allows surgical teams to gain experience with rare adrenal cases. High-volume centers often provide faster inpatient flow once a treatment path is chosen.
Patient Consensus: Patients emphasize that specialist teams including endocrinologists and anesthesiologists are essential for surgery. This multidisciplinary approach is particularly vital for managing blood pressure during pheochromocytoma procedures.
Minimally invasive adrenalectomy is widely available across China at tertiary hospitals and university centers. Conventional laparoscopic surgery is now the standard care for most benign adrenal tumors. Leading facilities in major cities like Xiamen and Guangzhou offer robotic-assisted surgery using advanced Da Vinci systems.
Bookimed Expert Insight: Hospital volume is a stronger quality signal than the specific technology used. Xiamen Humanity Hospital treats 1,000,000 patients per year and maintains 47 clinical departments. This high patient flow typically ensures that surgeons manage complex adrenal cases more frequently than at smaller regional centers. When choosing a facility, prioritize high-volume tertiary hospitals where endocrine surgical teams perform these procedures daily.
Patient Consensus: Patients note that while robotics is impressive, the surgeon's experience with adrenal tumors matters most. Many prefer high-volume laparoscopic teams over lower-volume robotic options in smaller cities.
High-risk peri-operative management for functional adrenal tumors requires specialized hormone-specific optimization. Clinical teams prioritize alpha-adrenergic blockade for pheochromocytomas to stabilize blood pressure. Cortisol-producing tumors require stress-dose glucocorticoids. Surgeons utilize robotic platforms like da Vinci for precision during tumor manipulation to prevent hemodynamic crises.
Bookimed Expert Insight: Xiamen Humanity Hospital manages over 1,000,000 patients annually across 47 departments. This high volume allows for tight coordination between oncology and endocrinology teams. Data shows that integrated preoperative planning is vital when using the da Vinci robot. This ensures patients are stable before the high-precision surgical phase begins.
Patient Consensus: Patients emphasize that blood pressure swings are a major concern during surgery. They note that recovery often involves emotional changes and frequent vital sign monitoring in the ICU.
Renowned hospitals in China for adrenal tumor care include Peking Union Medical College Hospital (PUMCH), Ruijin Hospital, and Guangzhou Fuda Cancer Hospital. These Class A Tertiary institutions provide multidisciplinary treatment. They integrate endocrinology, urology, and oncology expertise for complex cases. Many utilize advanced robotic systems and minimally invasive techniques.
Bookimed Expert Insight: Xiamen Humanity Hospital stands out for its massive scale and research focus. It handles 1,000,000 patients annually and manages 47 clinical departments simultaneously. This high volume often correlates with refined surgical efficiency for complex abdominal procedures. Patients benefit from a system designed for high-capacity diagnostic and therapeutic throughput.
Patient Consensus: Patients emphasize finding surgeons with high-volume experience in functional tumors like pheochromocytoma. Expertise in managing blood pressure and hormone levels before surgery is considered more important than the hospital brand.
Advanced non-surgical adrenal tumor treatments in China center on image-guided thermal ablation and targeted vascular interventions. These minimally invasive techniques destroy tumor tissue while preserving healthy organs. Leading Chinese hospitals utilize cryoablation, microwave ablation, and arterial embolization to manage endocrine-active or metastatic lesions safely.
Bookimed Expert Insight: While surgical robotic systems like Da Vinci are available at centers like Xiamen Humanity Hospital, non-surgical ablation in China requires highly specific interventional radiology expertise. Large tertiary hospitals serving over 1,000,000 patients annually often provide the most robust multidisciplinary teams. These centers are better equipped to manage the sudden blood pressure spikes common during adrenal tumor manipulation.
Patient Consensus: Patients emphasize the need for a combined team of endocrinologists and radiologists to manage hormone surges. Many note that thorough diagnostic imaging is more critical than the treatment itself for determining safety.
International patient departments in Chinese hospitals provide comprehensive language and logistical support for adrenal tumor treatment. Services include medical translation during consultations and visa invitation letters. Hospitals also arrange airport transfers and coordinate local lodging near major medical facilities like Xiamen Humanity Hospital.
Bookimed Expert Insight: Xiamen Humanity Hospital manages over 1,000,000 patients annually and serves regions from Europe to Asia. This high volume allows their 47 departments to streamline care for international cases. Patients often find better support at such large-scale facilities compared to smaller regional centers.
Patient Consensus: Patients note that bringing printed English summaries of prior scans helps speed up the intake process significantly. Having a medical facilitator is often recommended to bridge communication gaps during pharmacy visits or laboratory tests.